Thrombin up-regulates vascular endothelial growth factor in experimental gliomas

Neurological Research

Volumn 31, Issue 7, 2009, Pages 759-765

  Xu, Ying ^a,b   Gu, Yuxiang ^a   Keep, Richard F ^a   Heth, Jason ^a   Muraszko, Karin M ^a   Xi, Guohua ^a   Hua, Ya ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b TONGJI UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Gliomas; Hypoxia inducible factor 1 ; Mitogen activated protein kinases; Vascular endothelial growth factor

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; THROMBIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; RAT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLIOMA; HEMOSTATICS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDAZOLES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION; THROMBIN; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68849090292     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X385699     Document Type: Article

References (34)

1. Hua Y, Keep RF, Schallert T, et al. A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model. Acta Neurochir Suppl 2003; 86: 503-506
2. Hua Y, Tang L, Keep RF, et al. The role of thrombin in gliomas. J Thromb Haemost 2005; 3: 1-7
3. Hua Y, Tang LL, Fewel ME, et al. Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models. Acta Neurochir Suppl 2005; 95: 403-406
4. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999; 274: 23969-23976 (Pubitemid 129528439)
5. Yamahata H, Takeshima H, Kuratsu J, et al. The role of thrombin in the neo-vascularization of malignant gliomas: An intrinsic modulator for the up-regulation of vascular endothelial growth factor. Int J Oncol 2002; 20: 921-928
6. Sarker KP, Biswas KK, Yamaji K, et al. Inhibition of thrombininduced vascular endothelial growth factor production in human neuroblastoma (nb-1) cells by argatroban. Pathophysiol Haemost Thromb 2005; 34: 41-47 (Pubitemid 41642804)
7. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25 (Pubitemid 27076453)
8. Berse B, Brown LF, van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3: 211-220 (Pubitemid 23084552)
9. Damert A, Machein M, Breier G, et al. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997; 57: 3860-3864 (Pubitemid 27381236)
10. Jensen RL, Ragel BT, Whang K, et al. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol 2006; 78: 233-247 (Pubitemid 44018816)
11. Berra E, Pages G, Pouyssegur J. MAP kinases and hypoxia in the control of VEGF expression. Cancer Metast Rev 2000; 19: 139-145 (Pubitemid 32004703)
12. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765-26771 (Pubitemid 30688019)
13. Hanze J, Eul BG, Savai R, et al. RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation. Biochem Biophys Res Commun 2003; 312: 571-577 (Pubitemid 37468209)
14. Hua Y, Keep RF, Hoff JT, et al. Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab 2003; 23: 1448-1454 (Pubitemid 38018263)
15. Mizoguchi M, Betensky RA, Batchelor TT, et al. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: Correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol 2006; 65: 1181-1188 (Pubitemid 44885942)
16. Xi G, Keep RF, Hua Y, et al. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 1999; 30: 1247-1255 (Pubitemid 29259182)
17. Jiang Y, Wu J, Keep RF, et al. Hypoxia-inducible factor-1a accumulation in the brain after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 2002; 22: 689-696 (Pubitemid 34596461)
18. Wojtukiewicz MZ, Sierko E, Kisiel W. The role of hemostatic system inhibitors in malignancy. Semin Thromb Hemost 2007; 33: 621-642 (Pubitemid 350157006)
19. Xi G, Reiser G, Keep RF. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: Deleterious or protective? J Neurochem 2003; 84: 3-9
20. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407: 258-264
21. Wojtukiewicz MZ, Tang DG, Ben-Josef E, et al. Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res 1995; 55: 698-704
22. Tsopanoglou NE, Maragoudakis ME. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1. Semin Thromb Hemost 2007; 33: 680-687 (Pubitemid 350157012)
23. Weich HA, Iberg N, Klagsbrun M, et al. Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. J Cell Biochem 1991; 47: 158-164
24. Fischer I, Gagner JP, Law M, et al. Angiogenesis in gliomas: Biology and molecular pathophysiology. Brain Pathol 2005; 15: 297-310 (Pubitemid 41677429)
25. Zagzag D, Zhong H, Scalzitti JM, et al. Expression of hypoxiainducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression. Cancer 2000; 88: 2606-2618 (Pubitemid 30331970)
26. Zhong H, de Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5835
27. Lee KR, Kawai N, Kim S, et al. Mechanisms of edema formation after intracerebral hemorrhage: Effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 1997; 86: 272-278 (Pubitemid 27130687)
28. Berra E, Milanini J, Richard DE, et al. Signaling angiogenesis via p42/p44 map kinase and hypoxia. Biochem Pharmacol 2000; 60: 1171-1178
29. Birner P, Gatterbauer B, Oberhuber G, et al. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: Its impact on prognosis and on neoangiogenesis. Cancer 2001; 92: 165-171 (Pubitemid 32623053)
30. Sodhi A, Montaner S, Miyazaki H, et al. MAPK and AKT act cooperatively but independently on hypoxia inducible factor- 1alpha in rasv12 upregulation of VEGF. Biochem Biophys Res Commun 2001; 287: 292-300 (Pubitemid 32912498)
31. Maragoudakis ME, Tsopanoglou NE, Andriopoulou P, et al. Effects of thrombin/thrombosis in angiogenesis and tumour progression. Matrix Biol 2000; 19: 345-351 (Pubitemid 30665658)
32. Tsopanoglou NE, Maragoudakis ME. Role of thrombin in angiogenesis and tumor progression. Semin Thromb Hemost 2004; 30: 63-69 (Pubitemid 38457301)
33. Tsopanoglou NE, Papaconstantinou ME, Flordellis CS, et al. On the mode of action of thrombin-induced angiogenesis: Thrombin peptide, tp508, mediates effects in endothelial cells via alphavbeta3 integrin. Thromb Haemost 2004; 92: 846-857
34. Fang J, Yan L, Shing Y, et al. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res 2001; 61: 5731-5735 (Pubitemid 32769087)